A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

NCT06207305 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Appendiceal Adenocarcinoma
Intraperitoneal Paclitaxel

Interventions

DRUG: Dexamethasone
DRUG: Diphenhydramine
DRUG: Famotidine
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center